Effect of Antihypertensive Monotherapy and Combination Therapy on Arterial Distensibility and Left Ventricular Mass

American Journal of Hypertension

Volumn 17, Issue 1, 2004, Pages 37-42

  Neutel, Joel M ^a   Smith, David H G ^b   Weber, Michael A ^c  

^a Orange County Heart Institute and Research Center   (United States)

^b Memorial Research Medical Clinic   (United States)

^c SUNY Downstate Medical Center   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Arterial distensibility; Calcium channel blockers; Combination therapy

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTERY COMPLIANCE; ARTICLE; BORDERLINE HYPERTENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TITRIMETRY;

EID: 0346059328     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.08.002     Document Type: Article

References (30)

1. Havlik RJ, LaCroix AZ, Kleinman JC, Ingram DD, Harris T, Cornoni-Huntley J: Antihypertensive drug therapy and survival by treatment status in a national survey. Hypertension 1989;13(Suppl): 128-132.
2. Neutel JM, Smith DH, Graettinger WF, Winer RL, Weber MA: Heredity and hypertension: impact on metabolic characteristics. Am Heart J 1992:124:435-440.
3. Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F: Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998;21:597-603.
4. Furberg CD, Psaty BM, Pahor M, Alderman MH: Clinical implications of recent findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and other studies of hypertension. Ann Intern Med 2001;135:1074-1078.
5. Gibbons GH: Endothelial function as a determinant of vascular function and structure: a new therapeutic target. Am J Cardiol 1997;79:3-8.
6. McVeigh GE, Burns DE, Finkelstein SM, McDonald KM, Mock JE, Feske W, Carlyle PF, Flack J, Grimm R, Cohn JN: Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens 1991;4:245-251.
7. Cohn JN: Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision-making. Am J Hypertens 2001;14: 258S-263S.
8. Wing MH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ, for the Second Australian National Blood Pressure Study Group: A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-592.
9. Chio SS, inventor; Pulse Metric, assignee: Method and apparatus for determining blood pressure and cardiovascular condition. US patent 4 880 013. November 14, 1989.
10. Brinton TJ, Cotter B, Kailasam MT, Brown DL, Chio SS, O'Connor DT, DeMaria AN: Development and validation of a non-invasive method to determine arterial pressure and vascular compliance. Am J Cardiol 1997;80:323-330.
11. Parmer RJ, Cervenka JH, Stone RA: Baroreflex sensitivity and heredity in essential hypertension. Circulation 1992;85:497-503.
12. Weber MA, Neutel JM, Smith DHG, Graettinger WF: Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994;90:2291-2298.
13. Neutel JM, Smith DH, Graettinger WF, Weber MA: Dependency of arterial compliance on circulating neuroendocrine and metabolic factors in normal subjects. Am J Cardiol 1992;69:1340-1344.
14. Smith DH, Neutel JM: Change in arterial compliance as an early manifestation of hypertension. J Cardiovasc Risk 1997;4:267-270.
15. Mitchell GJ: Pulse pressure, arterial compliance and cardiovascular morbidity and mortality. Curr Opin Nephrol Hypertens 1999;8:335-342.
16. Hayoz D, Brunner HR: Remodelling of conduit arteries in hypertension: special emphasis on the mechanical and metabolic consequences of vascular hypertrophy. Blood Press Suppl 1997;2:39-42.
17. van den Berkmortel FW, van der Steen M, Hoogenboom H, Wollersheim H, van Langen H, Thien T: Progressive arterial wall stiffening in patients with increasing diastolic blood pressure. J Hum Hypertens 2001;15:685-691.
18. Khder Y, Bray-Desboscs L, Aliot E, Zannad F: Effects of blood pressure control on radial artery diameter and compliance in hypertensive patients. Am J Hypertens 1997;10:269-274.
19. Slama M, Safavian A, Tual JL, Laurent S, Safar ME: Effects of antihypertensive drugs on large artery compliance. Neth J Med 1995;47:162-168.
20. Sihm I, Schroeder AP, Aalkjaer C, Holm M, Morn B, Mulvany M, Thygesen K, Lederballe O: Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin- converting enzyme inhibitor-based regimen in hypertensive patients. Am J Cardiol 1995;76:38E-40E.
21. Safar ME, van Bortel CM, Struijker-Boudier HA: Resistance and conduit arteries following converting enzyme inhibition in hypertension. J Vasc Res 1997;34:67-81.
22. McVeigh GE: Effects of perindopril on cardiovascular remodeling. Am J Cardiol 2001;88(Suppl):28i-35i.
23. Blacher J, Amah G, Girerd X, Kheder A, Ben Mais H, London GM, Safar ME: Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 1997;10:1326-1334.
24. Schmieder RE, Martus P, Klingbeil A: Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996;275:1507-1513.
25. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001;104:1615-1621.
26. Staessen JA, Fagard R, Celis LT, Arabidze GC, Birkenhager WH: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764.
27. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-1762.
28. Khder Y, Bray des Boscs L, el Ghawi R, Meilhac B, Montestruc F, Stoltz JF, Zannad F: Calcium antagonists and thiazide diuretics have opposite effects on blood rheology and radial artery compliance in arterial hypertension: a randomized double-blind study. Fundam Clin Pharmacol 1998;12:457-462.
29. Giannattasio C: Radial artery compliance and distensibility in hypertension and hypertension-related conditions. Blood Press Suppl 1997;2:43-47.
30. Weber MA: The measurement of arterial properties in hypertension. Am J Hypertens 2001;14:183-185.